Logo image
Quantifiable bleeding in children supported by extracorporeal membrane oxygenation and outcome
Journal article   Peer reviewed

Quantifiable bleeding in children supported by extracorporeal membrane oxygenation and outcome

Marianne E. Nellis, Heidi Dalton and Oliver Karam
Critical Care Medicine, Vol.47(11)
2019

Abstract

Blood Transfusion Body Weight Chest Tubes Continuous Renal Replacement Therapy Extracorporeal Membrane Oxygenation Female Fibrinogen Hemorrhage Hospital Mortality Humans Infant Infant, Newborn Intensive Care Units, Pediatric Male Prospective Studies Renal Dialysis aminocaproic acid blood clotting factor 7 fibrinogen heparin lactic acid recombinant factor 7 unclassified drug fibrinogen Article assisted ventilation bleeding blood clotting test blood transfusion blood volume child clinical outcome cohort analysis comorbidity critically ill patient cryoprecipitate extracorporeal oxygenation fibrinogen blood level heart surgery hemodialysis hospital mortality human international normalized ratio length of stay major clinical study mortality observational study overall survival plasmapheresis platelet count priority journal prospective study bleeding body weight chest tube clinical trial continuous renal replacement therapy female infant male multicenter study newborn pediatric intensive care unit
Objectives: To evaluate the association between bleeding from chest tubes and clinical outcomes in children supported by extracorporeal membrane oxygenation. Design: Secondary analysis of a large observational cohort study. Setting: Eight pediatric institutions within the Eunice Kennedy Shriver National Institute of Child Health and Human Development's Collaborative Pediatric Critical Care Research Network. Patients: Critically ill children supported by extracorporeal membrane oxygenation. Interventions: None. Measurements and Main Results: Daily chest tube bleeding, results from hemostatic assays, transfusion volumes, 90-day PICU-free days, and mortality were collected prospectively by trained bedside extracorporeal membrane oxygenation specialists and research coordinators. Extracorporeal membrane oxygenation was employed in the care of 514 consecutive patients. Sixty percent of patients had at least one episode of chest tube bleeding (median chest tube blood volume over the entire extracorporeal membrane oxygenation course was 123 mL/kg [interquartile range, 47-319 mL/kg]). Twenty-six percent had at least 1 day of bleeding from the chest tube greater than 100mL/kg/d. The number of days with chest tube bleeding greater than 60mL/kg/d was independently associated with increased in-hospital mortality (adjusted odds ratio, 1.43; 95% CI, 1.05-1.97; p = 0.02) and decreased PICU-free days (beta coefficient, -4.2; 95% CI, -7.7 to -0.6; p = 0.02). The total amount of bleeding from chest tube were independently associated with increased mortality (per mL/kg/extracorporeal membrane oxygenation run; adjusted odds ratio, 1.002; 95% CI, 1.000-1.003; p = 0.04). Fibrinogen, weight, indication for extracorporeal membrane oxygenation, and need for hemodialysis were independently associated with chest tube bleeding, whereas platelet count, coagulation tests, heparin dose, and thrombotic events were not. Conclusions: In children supported by extracorporeal membrane oxygenation, chest tube bleeding above 60mL/kg/d was independently associated with worse clinical outcome. Low fibrinogen was independently associated with chest tube bleeding, whereas platelet count and hemostatic tests were not. Further research is needed to evaluate if interventions to prevent or stop chest tube bleeding influence the clinical outcome. © 2019 by the Society of Critical Care Medicine and Wolters Kluwer Health, Inc. All Rights Reserved.

Metrics

4 Record Views

Details

Logo image